Issued Patents All Time
Showing 1–25 of 36 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12391673 | LANCL ligands | Andrew Leber, Raquel Hontecillas | 2025-08-19 |
| 12281096 | Crystalline forms of piperazine-1,4-diylbis((6-(1H-benzo[d]imidazo-2-yl)pyridin-2yl)methanone) | Andrew Leber, Raquel Hontecillas | 2025-04-22 |
| 12150961 | Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith | Andrew Leber, Raquel Hontecillas | 2024-11-26 |
| 12145921 | Aromatic immunoregulatory compounds for treatment of inflammatory diseases | Andrew Leber, Raquel Hontecillas | 2024-11-19 |
| 12145920 | Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same | Andrew Leber, Raquel Hontecillas | 2024-11-19 |
| 11680045 | NLRX1 ligands | Andrew Leber, Raquel Hontecillas | 2023-06-20 |
| 11597717 | Substituted imidazoles as PLXDC2 ligands | Andrew Leber, Raquel Hontecillas, Nuria Tubau-Juni | 2023-03-07 |
| 11571419 | Lanthionine synthetase C-like 2-based therapeutics | Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas | 2023-02-07 |
| 11548885 | NLRX1 ligands | Andrew Leber, Nuria Tubau-Juni, Raquel Hontecillas | 2023-01-10 |
| 11492342 | Crystalline forms of piperazine-1,4-diylbis((6-(1H-benzo[d]imidazo-2-yl)pyridin-2yl)methanone) | Andrew Leber, Raquel Hontecillas | 2022-11-08 |
| 11459310 | LANCL ligands | Andrew Leber, Raquel Hontecillas | 2022-10-04 |
| 11377437 | Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using same | Andrew Leber, Raquel Hontecillas | 2022-07-05 |
| 11197891 | Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith | Andrew Leber, Raquel Hontecillas | 2021-12-14 |
| 11180473 | PLXDC2 ligands | Andrew Leber, Raquel Hontecillas, Nuria Tubau-Juni | 2021-11-23 |
| 11117881 | Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same | Andrew Leber, Raquel Hontecillas | 2021-09-14 |
| 11066364 | NLRX1 ligands | Andrew Leber, Raquel Hontecillas | 2021-07-20 |
| 11026888 | Functional beverage compositions and methods of using and making same | Nathan C. Briggs, Raquel Hontecillas-Magarzo | 2021-06-08 |
| 10849895 | Lanthionine synthetase C-like 2-based therapeutics | Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas | 2020-12-01 |
| 10682349 | Lanthionine synthetase C-like 2-based therapeutics | Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas | 2020-06-16 |
| 10676436 | NLRX1 ligands | Andrew Leber, Raquel Hontecillas | 2020-06-09 |
| 10493072 | Lanthionine synthetase C-like 2-based therapeutics | Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas | 2019-12-03 |
| 10487057 | NLRX1 ligands | Andrew Leber, Raquel Hontecillas | 2019-11-26 |
| 10201538 | Lanthionine synthetase C-like 2-based therapeutics | Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas | 2019-02-12 |
| 10028950 | Lanthionine synthetase C-like 2-based therapeutics | Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas | 2018-07-24 |
| 9839635 | Lanthionine synthetase C-like 2-based therapeutics | Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas | 2017-12-12 |